Physician profile
Emily Budden
NPI 1932662160
$2,292.44
in general payments reported to CMS, 2019-2025
13 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.99 · 2020: $11.70 · 2021: $24.22 · 2023: $1,675 · 2024: $279 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $873 · Education: $825 · Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $872.92 |
| Education | $824.99 |
| Food and Beverage | $492.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,652.27 | 2023 | Da Vinci Surgical System, Davinci Xi |
| Astellas Pharma US INC | $147.66 | 2024-2025 | Veozah |
| Abbvie INC. | $109.13 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $93.76 | 2024-2025 | Myfembree |
| Pfizer INC. | $86.00 | 2023-2025 | |
| Becton, Dickinson and Company | $38.02 | 2025 | Bd Onclarity |
| Merck Sharp & Dohme LLC | $35.87 | 2019-2025 | Gardasil 9 |
| Organon LLC | $27.56 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $24.45 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $24.22 | 2021 | |
| Coopersurgical, INC. | $18.19 | 2025 | Cook |
| Bayer Healthcare Pharmaceuticals INC. | $17.95 | 2024 | |
| Biogen, INC. | $17.36 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Budden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.